293 related articles for article (PubMed ID: 11709782)
1. Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapy.
Lathey JL; Tierney C; Chang SY; D'Aquila RT; Bettendorf DM; Alexander HC; Santini CD; Hughes AM; Barroga CF; Spector SA; Landes JE; Hammer SM; Katzenstein DA
J Infect Dis; 2001 Dec; 184(11):1402-11. PubMed ID: 11709782
[TBL] [Abstract][Full Text] [Related]
2. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
[TBL] [Abstract][Full Text] [Related]
3. Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection.
Singh KK; Barroga CF; Hughes MD; Chen J; Raskino C; McKinney RE; Spector SA
J Infect Dis; 2003 Nov; 188(10):1461-72. PubMed ID: 14624371
[TBL] [Abstract][Full Text] [Related]
4. Association of highly active antiretroviral therapy failure with chemokine receptor 5 wild type.
Bogner JR; Lutz B; Klein HG; Pollerer C; Troendle U; Goebel FD
HIV Med; 2004 Jul; 5(4):264-72. PubMed ID: 15236615
[TBL] [Abstract][Full Text] [Related]
5. Role of CCR5, CCR2 and SDF-1 gene polymorphisms in a population of HIV-1 infected individuals.
Mazzucchelli R; Corvasce S; Violin M; Riva C; Bianchi R; Dehò L; Velleca R; Cibella J; Bada M; Moroni M; Galli M; Balotta C
J Biol Regul Homeost Agents; 2001; 15(3):265-71. PubMed ID: 11693435
[TBL] [Abstract][Full Text] [Related]
6. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.
Apostolakis S; Baritaki S; Krambovitis E; Spandidos DA
J Clin Virol; 2005 Dec; 34(4):310-4. PubMed ID: 16286055
[TBL] [Abstract][Full Text] [Related]
7. Distribution of CCR5delta32, CCR2-64I and SDF1-3'A and plasma levels of SDF-1 in HIV-1 seronegative North Indians.
Verma R; Gupta RB; Singh K; Bhasin R; Anand Shukla A; Chauhan SS; Luthra K
J Clin Virol; 2007 Mar; 38(3):198-203. PubMed ID: 17240189
[TBL] [Abstract][Full Text] [Related]
8. The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-1 infection.
van Rij RP; Broersen S; Goudsmit J; Coutinho RA; Schuitemaker H
AIDS; 1998 Jun; 12(9):F85-90. PubMed ID: 9662191
[TBL] [Abstract][Full Text] [Related]
9. [Do polymorphisms of the SDF1 and CCR2b genes modify the course of hepatitis C or HIV/HCV co-infection?].
Woitas RP; Ahlenstiel G; Iwan A; Rockstroh JK; Brackmann HH; Kupfer B; Matz B; Offergeld R; Sauerbruch T; Spengler U
Dtsch Med Wochenschr; 2002 Sep; 127(36):1807-12. PubMed ID: 12215924
[TBL] [Abstract][Full Text] [Related]
10. Stromal cell-derived factor-1 genotype, coreceptor tropism, and HIV type 1 disease progression.
Daar ES; Lynn HS; Donfield SM; Lail A; O'Brien SJ; Huang W; Winkler CA;
J Infect Dis; 2005 Nov; 192(9):1597-605. PubMed ID: 16206074
[TBL] [Abstract][Full Text] [Related]
11. [Distribution of HIV resistance CCR5-delta 32, CCR2-64 I and SDF1-3'A alleles and their polymorphisms in the Han population in China].
Wang F; Jin L; Lei Z; Shi H; Hong W; Xu D; Shi M; Jiang J; Wang Y; Zhang B; Liu M; Li Y
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Aug; 21(4):256-60. PubMed ID: 11860793
[TBL] [Abstract][Full Text] [Related]
12. Distribution of three HIV-1 resistance-conferring polymorphisms (SDF1-3'A, CCR2-641, and CCR5-delta32) in global populations.
Su B; Sun G; Lu D; Xiao J; Hu F; Chakraborty R; Deka R; Jin L
Eur J Hum Genet; 2000 Dec; 8(12):975-9. PubMed ID: 11175286
[TBL] [Abstract][Full Text] [Related]
13. Stromal cell-derived factor (SDF) 1-3'A polymorphism may play a role in resistance to HIV-1 infection in seronegative high-risk Thais.
Tiensiwakul P
Intervirology; 2004; 47(2):87-92. PubMed ID: 15192272
[TBL] [Abstract][Full Text] [Related]
14. The effect of stromal cell-derived factor 1 (SDF1/CXCL12) genetic polymorphism on HIV-1 disease progression.
Reiche EM; Ehara Watanabe MA; Bonametti AM; Kaminami Morimoto H; Akira Morimoto A; Wiechmann SL; Breganó JW; Matsuo T; Vissoci Reiche F; Miranda HC; Brajão Oliveira K; Vogler IH; Siscar AR
Int J Mol Med; 2006 Oct; 18(4):785-93. PubMed ID: 16964435
[TBL] [Abstract][Full Text] [Related]
15. Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study.
Nahon P; Sutton A; Rufat P; Faisant C; Simon C; Barget N; Trinchet JC; Beaugrand M; Gattegno L; Charnaux N
Eur J Gastroenterol Hepatol; 2007 May; 19(5):425-31. PubMed ID: 17413295
[TBL] [Abstract][Full Text] [Related]
16. Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression.
de Roda Husman AM; van Rij RP; Blaak H; Broersen S; Schuitemaker H
J Infect Dis; 1999 Oct; 180(4):1106-15. PubMed ID: 10479137
[TBL] [Abstract][Full Text] [Related]
17. Identification of two distinct subsets of long-term nonprogressors with divergent viral activity by stromal-derived factor 1 chemokine gene polymorphism analysis.
Balotta C; Bagnarelli P; Corvasce S; Mazzucchelli R; Colombo MC; Papagno L; Santambrogio S; Ridolfo AL; Violin M; Berlusconi A; Velleca R; Facchi G; Moroni M; Clementi M; Galli M
J Infect Dis; 1999 Aug; 180(2):285-9. PubMed ID: 10395841
[TBL] [Abstract][Full Text] [Related]
18. Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1.
Liu H; Hwangbo Y; Holte S; Lee J; Wang C; Kaupp N; Zhu H; Celum C; Corey L; McElrath MJ; Zhu T
J Infect Dis; 2004 Sep; 190(6):1055-8. PubMed ID: 15319853
[TBL] [Abstract][Full Text] [Related]
19. Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3'A genotype, and expression of CXCR4 on T lymphocytes: their impact on resistance to human immunodeficiency virus type 1 infection and its progression.
Soriano A; Martínez C; García F; Plana M; Palou E; Lejeune M; Aróstegui JI; De Lazzari E; Rodriguez C; Barrasa A; Lorenzo JI; Alcamí J; del Romero J; Miró JM; Gatell JM; Gallart T
J Infect Dis; 2002 Oct; 186(7):922-31. PubMed ID: 12232832
[TBL] [Abstract][Full Text] [Related]
20. CC chemokine receptor 5 delta32 and CC chemokine receptor 2 64I polymorphisms do not influence the virologic and immunologic response to antiretroviral combination therapy in human immunodeficiency virus type 1-infected patients.
Wit FW; van Rij RP; Weverling GJ; Lange JM; Schuitemaker H
J Infect Dis; 2002 Dec; 186(12):1726-32. PubMed ID: 12447757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
